Over 4,000 people downloaded Courage Against Cancer’s free guides last month. Now, one small $5 donation can help bring life-saving treatments closer to FDA approval — so one day, no child or family will be denied care because of cost.
Tag: ovarian cancer
Categories
Anti Cancer Breakthrough Therapies cancer research Coco the Koala Reports Courage Foundation Projects drug repurposing Drug Repurposing & Innovation Integrative Oncology Insights integrative-oncology Ivermectin MD Anderson Mebendazole Natural Treatments Non-Chemo Cancer Treatments Repurposed Drug Studies Research & Science Research News & Updates
Coco’s Big News: Courage Against Cancer Joins Forces with MD Anderson!
G’day mates — it’s me, Coco the Koala, and I can hardly contain my excitement! Today’s a historic moment for our Courage Against Cancer family. 🧬
We’ve just submitted our very first Sponsored Research Agreement (SRA) to MD Anderson Cancer Center — one of the world’s leading institutions in cancer research. Together, we’re launching a preclinical trial studying ivermectin and mebendazole as potential treatments against ovarian cancer.
It’s the first courageous step toward FDA-approved, non-chemotherapy cancer therapies — and I’m beaming with hope! Stay tuned as we climb this new branch of discovery, one brave leaf at a time.
Stay Courageous, mates. Healing is possible.
— Coco the Koala 🐨
In recent years, two existing drugs—Ivermectin and Mebendazole—have captured the attention of researchers and healthcare professionals alike for their potential anti-cancer effects. As the quest for non-chemotherapy, non-radiation therapies advances, understanding how these drugs could reshape cancer treatment is becoming increasingly vital. This article delves into the science behind IVM and MBZ, illuminating their mechanisms, available research, and the promise they hold for the future of oncology.
Courage Against Cancer 